Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.18 CAD
Change Today -0.005 / -2.70%
Volume 160.7K
LMD On Other Exchanges
As of 1:44 PM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

led medical diagnostics inc (LMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/17/15 - C$0.35
52 Week Low
08/24/15 - C$0.17
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

led medical diagnostics inc (LMD) Related Businessweek News

No Related Businessweek News Found

led medical diagnostics inc (LMD) Details

LED Medical Diagnostics Inc. operates as a dental imaging services and technology company in North America. Its products include Velscope Vx system to examine the oral mucosa and screen for tissue abnormalities, including early stage oral cancer and pre-cancer; VELscope Vx Camera kit for fluorescence photography; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, the single use plastic sheaths that allow proper ventilation for VELscope Vx scope while preventing debris buildup and cross contamination in the operatory; and Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. The company sells its products to dentists and dental specialists. It markets its products through distribution partners, as well as direct mail/e-mail and advertising in industry journals, and personal visits. The company has an agreement with BC Cancer Agency to create and commercialize a progression-risk assessment test for oral cancer. LED Medical Diagnostics Inc. was founded in 2003 and is headquartered in Vancouver, Canada.

29 Employees
Last Reported Date: 08/31/15
Founded in 2003

led medical diagnostics inc (LMD) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $225.0K
Vice President of Sales & Marketing, Director...
Total Annual Compensation: $220.0K
Total Annual Compensation: $286.4K
Compensation as of Fiscal Year 2014.

led medical diagnostics inc (LMD) Key Developments

LED Medical Diagnostics, Inc., Annual General Meeting, Nov 27, 2015

LED Medical Diagnostics, Inc., Annual General Meeting, Nov 27, 2015., at 10:00 Pacific Standard Time. Location: Farris, Vaughan, Wills & Murphy LLP. Agenda: To receive the audited financial statements of the corporation for the financial year ended December 31, 2014 and the report of the auditors thereon; to appoint Grant Thornton LLP as auditors of the corporation for the coming year and to authorize the board of directors to fix the auditors' remuneration; to elect the directors of the corporation for the ensuing year; to approve the stock option plan of the corporation; and to transact such other business as may properly come before the meeting.

LED Medical Diagnostics, Inc. Presents at Aegis Capital Corp 2015 Growth Conference, Oct-09-2015 11:25 AM

LED Medical Diagnostics, Inc. Presents at Aegis Capital Corp 2015 Growth Conference, Oct-09-2015 11:25 AM. Venue: The Encore at Wynn, 3131 S Las Vegas Blvd, Las Vegas, NV 89109, United States.

LED Medical Diagnostics Announces Issuance of Senior Secured Debentures Totaling USD 500,000

LED Medical Diagnostics Inc. announced that it is completing the second tranche to the previously announced debenture financing. In this second tranche the Company will issue USD 500,000 of 10% senior secured debentures each in the amount of USD 10,000 and maturing after 12 months. The lender for all Debentures will be the Bloom Burton Healthcare Lending Trust. The subscription price for each Unit is USD 10,000. The Company is granting the Warrants as a loan bonus in accordance with Exchange Policy 5.1 of the TSX Venture Exchange and each such Warrant will entitle the holder thereof to acquire one common share in the capital of the Company for USD 0.28 for a period of 12 months from the closing of the issuance of the Debentures. The proceeds will be used by LED for general corporate purposes. All securities issued in connection with the transaction are subject to a hold period expiring four months after the closing date. The completion of the private placement is subject to final approval of the TSX-Venture Exchange which will be evidenced by the issuance of the Exchange bulletin.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LMD:CN C$0.18 CAD -0.005

LMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LMD.
View Industry Companies

Industry Analysis


Industry Average

Valuation LMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.2x
Price/Book 6.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.0x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact LED MEDICAL DIAGNOSTICS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at